ARTICLE | Company News
Arena, Boehringer Ingelheim deal
January 18, 2016 8:00 AM UTC
Arena granted Boehringer exclusive, worldwide rights to develop and commercialize undisclosed oral, small molecules against an undisclosed GPCR. The companies also will conduct joint research to ident...